Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02233478 · ClinicalTrials.gov registry record · NA

Comparing the Effect of Whey and Soy Protein on the Absorption of Pomegranate Polyphenols in the Human Body

A NA study of Healthy, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT02233478: Completed NA study of Healthy, sponsored by University of California, Los Angeles.

NCT02233478 is a NA study of Healthy that has completed, run by University of California, Los Angeles. The registered enrollment target is 18 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02233478, a NA study of Healthy, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

This study is comparing the quantity of active metabolites from consuming pomegranate juice in three different preparations. People who participate in this study will come in to the Center for a screening visit, which includes a blood test and medical history. If you qualify based on the screening visit, you will then come in to the Center while fasting in the morning on three different days. You will eat a standardized breakfast and drink one of three juices, and then remain for metabolic testing at the Center for a period of time after eating. You will also be provided a standardized lunch and water during this period. Each of those visits will last about 7 hours. During this time, and for the rest of the 24 hours following drinking the juice, you will collect all of your urine. Following all three of these 7-hour visits, you will return to the Center again the next day for a fasting blood draw, drop off your urine sample, and pick up a new container to collect another 24 hour urine sample. The following day, you will return to the Center to drop off your second urine sample collection.

Primary Outcome

Blood samples were collected at baseline, 0.5, 1, 2, 3, 4, 6 and 24 h after ingestion of pomegranate juice (PJ) alone, or PJ mixed with soy protein, or PJ mixed with soybean flour. Plasma concentration of ellagic acid at each time point was determined to create a pharmacokinetic parameter area under the curve.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Pomegranate Juice
  • DIETARY_SUPPLEMENT Soybean Flour Protein
  • DIETARY_SUPPLEMENT Soy Isolate Protein

Study Locations (1)

California

  • UCLA Center for Human Nutrition - Los Angeles

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2014-08
Est. Completion 2015-01
Phase NA

What the finished NCT02233478 record still lists

NCT02233478 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Pomegranate Juice is the first listed.

NCT02233478 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02233478 about?

NCT02233478 is a clinical study titled "Comparing the Effect of Whey and Soy Protein on the Absorption of Pomegranate Polyphenols in the Human Body". This study is comparing the quantity of active metabolites from consuming pomegranate juice in three different preparations. People who participate in this study will come in to the Center for a screening visit, which includes a blood test and medical history. If you qualify based on the screening v...

What is the current status of trial NCT02233478?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2014-08. Estimated completion is 2015-01.

What conditions does trial NCT02233478 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT02233478?

The interventions under investigation include: Pomegranate Juice (DIETARY_SUPPLEMENT), Soybean Flour Protein (DIETARY_SUPPLEMENT), Soy Isolate Protein (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02233478?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02233478 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02233478's enrollment target sits among peer trials

18 904th of 1090 higher than 163 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02233478, the US trial registry maintained by the National Library of Medicine. NCT02233478 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.